1123 related articles for article (PubMed ID: 25529533)
61. Biodistribution and antitumoral effect of long-circulating and pH-sensitive liposomal cisplatin administered in Ehrlich tumor-bearing mice.
Araújo JG; Mota Ld; Leite EA; Maroni Lde C; Wainstein AJ; Coelho LG; Savassi-Rocha PR; Pereira MT; de Carvalho AT; Cardoso VN; De Oliveira MC
Exp Biol Med (Maywood); 2011 Jul; 236(7):808-15. PubMed ID: 21685237
[TBL] [Abstract][Full Text] [Related]
62. Heat-activated thermosensitive liposomal cisplatin (HTLC) results in effective growth delay of cervical carcinoma in mice.
Dou YN; Zheng J; Foltz WD; Weersink R; Chaudary N; Jaffray DA; Allen C
J Control Release; 2014 Mar; 178():69-78. PubMed ID: 24440663
[TBL] [Abstract][Full Text] [Related]
63. Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells.
Tavassolian F; Kamalinia G; Rouhani H; Amini M; Ostad SN; Khoshayand MR; Atyabi F; Tehrani MR; Dinarvand R
Int J Pharm; 2014 Jun; 467(1-2):123-38. PubMed ID: 24680951
[TBL] [Abstract][Full Text] [Related]
64. Tumor-type-dependent vascular permeability constitutes a potential impediment to the therapeutic efficacy of liposomal oxaliplatin.
Abu Lila AS; Matsumoto H; Doi Y; Nakamura H; Ishida T; Kiwada H
Eur J Pharm Biopharm; 2012 Aug; 81(3):524-31. PubMed ID: 22554766
[TBL] [Abstract][Full Text] [Related]
65. A poly(γ, L-glutamic acid)-citric acid based nanoconjugate for cisplatin delivery.
Xiong Y; Jiang W; Shen Y; Li H; Sun C; Ouahab A; Tu J
Biomaterials; 2012 Oct; 33(29):7182-93. PubMed ID: 22795851
[TBL] [Abstract][Full Text] [Related]
66. Antitumor activity of adriamycin-incorporated polymeric micelles of poly(gamma-benzyl L-glutamate)/poly(ethylene oxide).
Jeong YI; Na HS; Cho KO; Lee HC; Nah JW; Cho CS
Int J Pharm; 2009 Jan; 365(1-2):150-6. PubMed ID: 18786625
[TBL] [Abstract][Full Text] [Related]
67. Magnetically Targeted Nanocapsules for PAA-Cisplatin-Conjugated Cores in PVA/SPIO Shells via Surfactant-Free Emulsion for Reduced Nephrotoxicity and Enhanced Lung Cancer Therapy.
Chiang CS; Tseng YH; Liao BJ; Chen SY
Adv Healthc Mater; 2015 May; 4(7):1066-75. PubMed ID: 25656800
[TBL] [Abstract][Full Text] [Related]
68. Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice.
Moreno D; Zalba S; Navarro I; Tros de Ilarduya C; Garrido MJ
Eur J Pharm Biopharm; 2010 Feb; 74(2):265-74. PubMed ID: 19883755
[TBL] [Abstract][Full Text] [Related]
69. PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties.
Avgoustakis K; Beletsi A; Panagi Z; Klepetsanis P; Karydas AG; Ithakissios DS
J Control Release; 2002 Feb; 79(1-3):123-35. PubMed ID: 11853924
[TBL] [Abstract][Full Text] [Related]
70. Preparation, in vitro and in vivo evaluation of mPEG-PLGA nanoparticles co-loaded with syringopicroside and hydroxytyrosol.
Guan Q; Sun S; Li X; Lv S; Xu T; Sun J; Feng W; Zhang L; Li Y
J Mater Sci Mater Med; 2016 Feb; 27(2):24. PubMed ID: 26704541
[TBL] [Abstract][Full Text] [Related]
71. Co-delivery of polymeric metformin and cisplatin by self-assembled core-membrane nanoparticles to treat non-small cell lung cancer.
Xiong Y; Zhao Y; Miao L; Lin CM; Huang L
J Control Release; 2016 Dec; 244(Pt A):63-73. PubMed ID: 27840166
[TBL] [Abstract][Full Text] [Related]
72. Preparation of poly-l-lysine-based nanoparticles with pH-sensitive release of curcumin for targeted imaging and therapy of liver cancer in vitro and in vivo.
Yang DH; Kim HJ; Park K; Kim JK; Chun HJ
Drug Deliv; 2018 Nov; 25(1):950-960. PubMed ID: 29658319
[TBL] [Abstract][Full Text] [Related]
73. Drug-interactive mPEG-
Gong F; Wang R; Zhu Z; Duan J; Teng X; Cui ZK
Drug Deliv; 2020 Dec; 27(1):238-247. PubMed ID: 32003299
[TBL] [Abstract][Full Text] [Related]
74. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy.
Ko J; Park K; Kim YS; Kim MS; Han JK; Kim K; Park RW; Kim IS; Song HK; Lee DS; Kwon IC
J Control Release; 2007 Nov; 123(2):109-15. PubMed ID: 17894942
[TBL] [Abstract][Full Text] [Related]
75. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
[TBL] [Abstract][Full Text] [Related]
76. Methoxy poly (ethylene glycol)-block-poly (glutamic acid)-graft-6-(2-nitroimidazole) hexyl amine nanoparticles for potential hypoxia-responsive delivery of doxorubicin.
Ahmad Z; Lv S; Tang Z; Shah A; Chen X
J Biomater Sci Polym Ed; 2016; 27(1):40-54. PubMed ID: 26489768
[TBL] [Abstract][Full Text] [Related]
77. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation.
Xu H; Yang D; Cai C; Gou J; Zhang Y; Wang L; Zhong H; Tang X
Acta Biomater; 2015 Apr; 16():156-68. PubMed ID: 25662165
[TBL] [Abstract][Full Text] [Related]
78. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
79. Formulation conditions on the drug loading properties of polymeric micelles.
Zhou J; Jiang XH
Pak J Pharm Sci; 2019 Mar; 32(2):607-615. PubMed ID: 31081773
[TBL] [Abstract][Full Text] [Related]
80. Prominent Enhancement of Cisplatin Efficacy with Optimized Methoxy Poly(ethylene glycol)-Polycaprolactone Block Copolymeric Nanoparticles.
Yen YT; Wang X; Zhang H; Wang C; Lin Z; Xie C; Liu Q; Wang L; Yu L; Li X; Lv X; Liu B; Li R
J Biomed Nanotechnol; 2020 Mar; 16(3):335-343. PubMed ID: 32493543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
